Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer

Abstract

During the editorial office formatting of Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer (Cancer Biology & Therapy 2007; 6(10): 1632 - 1637) by Kiranmayi Tadi, Badithe T. Ashok, Yuangen Chen, Debabrata Banerjee, Barbara Wysocka-Skrzela, Jerzy Konopa, Zbigniew Darzynkiewicz and Raj K. Tiwari, an error occurred on page 1634, the text description and legend for figure 3 are correct but the image is not correct. Figure 4 was used for both figure 3 and 4. Please refer to the image 3 posted below.

This article refers to:

Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer